Core Viewpoint - The company reported significant growth in revenue and net profit for the fiscal year 2025, indicating strong performance in the blood purification equipment market [1] Financial Performance - The company achieved total operating revenue of 807 million yuan, an increase of 42.23% compared to the same period last year [1] - The net profit attributable to the parent company was 143 million yuan, reflecting a substantial increase of 101.89% year-on-year [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 138 million yuan, which represents a 141.34% increase compared to the previous year [1] Market Position and Product Performance - The company is a leading player in the domestic blood purification equipment sector, benefiting from technological advantages and strong brand recognition [1] - The market share of the company's products has been steadily increasing, contributing to the growth in sales revenue of blood purification equipment [1] - Sales revenue from self-produced blood purification consumables saw a significant increase during the reporting period [1] Cost and Profitability - With the increase in production and sales volume, the fixed cost per unit of self-produced consumables has decreased, leading to an improvement in gross profit margin [1] - Overall profitability of the company has strengthened as a result of these factors [1]
山外山(688410.SH):2025年度净利润1.43亿元,同比增加101.89%